Use of CGM during Early Weeks of COVID-19 Found to Improve Time in Range
February 17, 2021

A new review of >60 000 patients with diabetes found CGM use during the early weeks of the COVID-19 pandemic improved their time in range.

A1c Variability Predicts CVD in Type 2 Diabetes, Hypoglycemia May Mediate Impact
February 08, 2021

Variability in A1c during the first 2 years after T2D diagnosis is a strong predictor of CV disease; study authors note the risk may be mediated by severe hypoglycemic episodes.

Brigham & Women's Diabetes Expert Highlights 2020 Research
January 29, 2021

Director of the Brigham and Women's Diabetes Program Marie McDonnell, MD, talked with our editor about 2020 studies on SGLT-2 inhibitors, insulin icodec, and more.